Sign up today to learn more about Benchling stock

EquityZen is a marketplace for shares of proven pre IPO tech companies

Benchling Stock

Cloud-Based Research Platform

Founded

2012

Notable Investors

Thrive Capital

Headquarters

San Francisco CA, US

Total Funding

$425M

About Benchling Stock

Benchling is a modern software platform purpose-built for life science R&D. Benchling claims its platform can help manage techniques like CRISPR, CAR-T immunotherapy, and genetic engineering with a suite of cloud applications to design DNA and collaborate on experiments, manage research workflows, and make critical R&D decisions. Benchling is used for research on biotherapeutics, biofuels, and biomaterials at life science companies and academic labs. 

Benchling was founded in 2012 and is headquartered in San Francisco, California, United States. Notable investors include Thrive Capital, Y Combinator, and SV Angel.

Investors

Sequoia Capital Global Equities

Chime, Olive, Clari, Course Hero, Outreach, Benchling, Virta Health

Funding History

January 2015$6.1M
April 2016$7.0M
March 2018$18.2M
April 2019$37.0M
March 2020$50.5M
March 2021$200M
October 2021$95.0M
October 2021$11.0M

Management

Chief Executive Officer

Sajith Wickramasekara

Chief Financial Officer

Richard Wong

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo